[
  {
    "ts": null,
    "headline": "Trump Taps Vaccine Skeptic RFK Jr. to Lead HHS. Moderna, Novavax Stock Slide.",
    "summary": "The prospect of Kennedy leading HHS or a similar agency has cast major uncertainties over the health system.",
    "url": "https://finnhub.io/api/news?id=bc49ecdac06820463ed268fdb543b9746368f4ce82e95dad58cc26b78ac64ba5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731621360,
      "headline": "Trump Taps Vaccine Skeptic RFK Jr. to Lead HHS. Moderna, Novavax Stock Slide.",
      "id": 131359223,
      "image": "https://s.yimg.com/ny/api/res/1.2/L13b9rKy1ARhsXNaz8I9Vw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/Barrons.com/224a35b5a448c72fc7c732a541e7fce8",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "The prospect of Kennedy leading HHS or a similar agency has cast major uncertainties over the health system.",
      "url": "https://finnhub.io/api/news?id=bc49ecdac06820463ed268fdb543b9746368f4ce82e95dad58cc26b78ac64ba5"
    }
  },
  {
    "ts": null,
    "headline": "Moderna, Novavax stocks slide after Trump nominates Robert F. Kennedy Jr. to be top health official",
    "summary": "Vaccine stocks slid late Thursday as reports stated noted anti-vaccine politician Robert Kennedy Jr. will serve as the next head of the Department of Health and Human Services.",
    "url": "https://finnhub.io/api/news?id=328887ffeb8a0fb8d0d8423e45d2c6d4d2d04ebcca7bb79260bc090fecd04f3e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731619682,
      "headline": "Moderna, Novavax stocks slide after Trump nominates Robert F. Kennedy Jr. to be top health official",
      "id": 131373969,
      "image": "https://s.yimg.com/ny/api/res/1.2/NHea86qnKykuWa0XpvOD1w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://s.yimg.com/os/creatr-uploaded-images/2024-11/c89a65b0-a2ca-11ef-b7f7-ed7acdf864ff",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Vaccine stocks slid late Thursday as reports stated noted anti-vaccine politician Robert Kennedy Jr. will serve as the next head of the Department of Health and Human Services.",
      "url": "https://finnhub.io/api/news?id=328887ffeb8a0fb8d0d8423e45d2c6d4d2d04ebcca7bb79260bc090fecd04f3e"
    }
  },
  {
    "ts": null,
    "headline": "Moderna, Novovax stocks slide after Trump nominates Robert F. Kennedy Jr. to be top health official",
    "summary": "Vaccine stocks slid late Thursday as reports stated noted anti-vaccine politician Robert Kennedy Jr. will serve as the next head of the Department of Health and Human Services.",
    "url": "https://finnhub.io/api/news?id=f83fed6b8745aea08f110a13595f37af5846d59987d0c29f4dfc3d52d2e8581d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731619682,
      "headline": "Moderna, Novovax stocks slide after Trump nominates Robert F. Kennedy Jr. to be top health official",
      "id": 131359226,
      "image": "https://s.yimg.com/ny/api/res/1.2/NHea86qnKykuWa0XpvOD1w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://s.yimg.com/os/creatr-uploaded-images/2024-11/c89a65b0-a2ca-11ef-b7f7-ed7acdf864ff",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Vaccine stocks slid late Thursday as reports stated noted anti-vaccine politician Robert Kennedy Jr. will serve as the next head of the Department of Health and Human Services.",
      "url": "https://finnhub.io/api/news?id=f83fed6b8745aea08f110a13595f37af5846d59987d0c29f4dfc3d52d2e8581d"
    }
  },
  {
    "ts": null,
    "headline": "Health Care Down Amid RFK Fears -- Health Care Roundup",
    "summary": "Health-care companies fell sharply after reports that Donald Trump will pick Robert F. Kennedy Jr. as his nominee for head of Health and Human Services Department. Vaccine makers Moderna and...",
    "url": "https://finnhub.io/api/news?id=5d8860e83599325329a28060741daa5b3730c5116b96c1d454606614b0fa323e",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731606735,
      "headline": "Health Care Down Amid RFK Fears -- Health Care Roundup",
      "id": 131359073,
      "image": "",
      "related": "MRNA",
      "source": "Finnhub",
      "summary": "Health-care companies fell sharply after reports that Donald Trump will pick Robert F. Kennedy Jr. as his nominee for head of Health and Human Services Department. Vaccine makers Moderna and...",
      "url": "https://finnhub.io/api/news?id=5d8860e83599325329a28060741daa5b3730c5116b96c1d454606614b0fa323e"
    }
  },
  {
    "ts": null,
    "headline": "Vaccine-maker stocks like Moderna, Pfizer drop as Trump picks RFK Jr. to lead HHS",
    "summary": "Vaccine-maker stocks like Moderna, Pfizer drop as Trump picks RFK Jr. to lead HHS",
    "url": "https://finnhub.io/api/news?id=3c75e2d2809b157edff8c245ac6eb34f918874a2fb6faf979b5c384e02cb9d41",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731602400,
      "headline": "Vaccine-maker stocks like Moderna, Pfizer drop as Trump picks RFK Jr. to lead HHS",
      "id": 131416302,
      "image": "",
      "related": "MRNA",
      "source": "MarketWatch",
      "summary": "Vaccine-maker stocks like Moderna, Pfizer drop as Trump picks RFK Jr. to lead HHS",
      "url": "https://finnhub.io/api/news?id=3c75e2d2809b157edff8c245ac6eb34f918874a2fb6faf979b5c384e02cb9d41"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Inc. stock underperforms Thursday when compared to competitors",
    "summary": "Moderna Inc. stock underperforms Thursday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=f4bc88f6895107a4660501cdf20bf6368b2064d9211a0333ee7e8b8a02e95f38",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731601920,
      "headline": "Moderna Inc. stock underperforms Thursday when compared to competitors",
      "id": 131432198,
      "image": "",
      "related": "MRNA",
      "source": "MarketWatch",
      "summary": "Moderna Inc. stock underperforms Thursday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=f4bc88f6895107a4660501cdf20bf6368b2064d9211a0333ee7e8b8a02e95f38"
    }
  },
  {
    "ts": null,
    "headline": "Fidelity Growth Company Fund Q3 2024 Review",
    "summary": "For the third quarter, Fidelity Growth Company Fund's Retail Class shares gained 1.34%, lagging \nthe 3.42% advance of the benchmark. Click here to read more.",
    "url": "https://finnhub.io/api/news?id=1063d4cf1b1f43d376102851ab09375221b2a4df66b12eb494507b97915ecd4c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731588900,
      "headline": "Fidelity Growth Company Fund Q3 2024 Review",
      "id": 131353222,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2071111658/image_2071111658.jpg?io=getty-c-w1536",
      "related": "MRNA",
      "source": "SeekingAlpha",
      "summary": "For the third quarter, Fidelity Growth Company Fund's Retail Class shares gained 1.34%, lagging \nthe 3.42% advance of the benchmark. Click here to read more.",
      "url": "https://finnhub.io/api/news?id=1063d4cf1b1f43d376102851ab09375221b2a4df66b12eb494507b97915ecd4c"
    }
  },
  {
    "ts": null,
    "headline": "The Oncology Bet Is Already Paying Off For Pfizer",
    "summary": "With the downfall of Covid-19, pharmaceutical companies turned to oncology in search for their next growth story. Earlier in October, Pfizer Inc (NYSE: PFE) reported its third quarter revenue grew 14% on an operational basis due to approved cancer products from Seagen it acquired last December. On the other hand, Moderna Inc (NASDAQ: MRNA) posted a surprise profit and higher than expected revenue following the launch of its updated Covid-19 vaccine earlier this year as focused on slashing costs.",
    "url": "https://finnhub.io/api/news?id=e84ce3a602357d20bee4b7bd007c9b71e07c6f3e65b8f8118353c95cabbf3553",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731543795,
      "headline": "The Oncology Bet Is Already Paying Off For Pfizer",
      "id": 131340999,
      "image": "https://media.zenfs.com/en/Benzinga/eeac3cc78e2352f7fe351184c2b1bf99",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "With the downfall of Covid-19, pharmaceutical companies turned to oncology in search for their next growth story. Earlier in October, Pfizer Inc (NYSE: PFE) reported its third quarter revenue grew 14% on an operational basis due to approved cancer products from Seagen it acquired last December. On the other hand, Moderna Inc (NASDAQ: MRNA) posted a surprise profit and higher than expected revenue following the launch of its updated Covid-19 vaccine earlier this year as focused on slashing costs.",
      "url": "https://finnhub.io/api/news?id=e84ce3a602357d20bee4b7bd007c9b71e07c6f3e65b8f8118353c95cabbf3553"
    }
  }
]